BRCA1 participates in DNA decatenation
- PMID: 15965487
- DOI: 10.1038/nsmb953
BRCA1 participates in DNA decatenation
Abstract
The tumor suppressor BRCA1 has an important function in the maintenance of genomic stability. Increasing evidence suggests that BRCA1 regulates cell cycle checkpoints and DNA repair after DNA damage. However, little is known about its normal function in the absence of DNA damage. Here we show that BRCA1 interacts and colocalizes with topoisomerase IIalpha in S phase cells. Similar to cells treated with the topoisomerase IIalpha inhibitor ICRF-193, BRCA1-deficient cells show lagging chromosomes, indicating a defect in DNA decatenation and chromosome segregation. More directly, BRCA1 deficiency results in defective DNA decatenation in vitro. Finally, topoisomerase IIalpha is ubiquitinated in a BRCA1-dependent manner, and topoisomerase IIalpha ubiquitination correlates with higher DNA decatenation activity. Together these results suggest an important role of BRCA1 in DNA decatenation and reveal a previously unknown function of BRCA1 in the maintenance of genomic stability.
Similar articles
-
Functional compatibility between isoform alpha and beta of type II DNA topoisomerase.J Cell Sci. 2004 Mar 1;117(Pt 7):1047-54. doi: 10.1242/jcs.00977. J Cell Sci. 2004. PMID: 14996935
-
Expression of cyclins A, E and topoisomerase II alpha correlates with centrosome amplification and genomic instability and influences the reliability of cytometric S-phase determination.BMC Cell Biol. 2003 Jul 22;4:8. doi: 10.1186/1471-2121-4-8. BMC Cell Biol. 2003. PMID: 12875657 Free PMC article.
-
Topoisomerase IIalpha-positive and BRCA1-negative phenotype: association with favorable response to epirubicin-based regimens for human breast cancers.Cancer Lett. 2008 Jun 8;264(1):44-53. doi: 10.1016/j.canlet.2008.01.015. Epub 2008 Feb 15. Cancer Lett. 2008. PMID: 18280644
-
The role of the BRCA1 tumor suppressor in DNA double-strand break repair.Mol Cancer Res. 2005 Oct;3(10):531-9. doi: 10.1158/1541-7786.MCR-05-0192. Mol Cancer Res. 2005. PMID: 16254187 Review.
-
Oh what a tangled web it weaves: BRCA1 and DNA decatenation.Cancer Cell. 2005 Aug;8(2):95-7. doi: 10.1016/j.ccr.2005.07.011. Cancer Cell. 2005. PMID: 16098462 Review.
Cited by
-
The decatenation checkpoint.Br J Cancer. 2007 Jan 29;96(2):201-5. doi: 10.1038/sj.bjc.6603537. Epub 2007 Jan 9. Br J Cancer. 2007. PMID: 17211475 Free PMC article. Review.
-
The Role of ARID1A in Endometrial Cancer and the Molecular Pathways Associated With Pathogenesis and Cancer Progression.In Vivo. 2019 May-Jun;33(3):659-667. doi: 10.21873/invivo.11524. In Vivo. 2019. PMID: 31028182 Free PMC article. Review.
-
Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications.J Cell Biol. 2023 Dec 4;222(12):e202209125. doi: 10.1083/jcb.202209125. Epub 2023 Nov 13. J Cell Biol. 2023. PMID: 37955972 Free PMC article. Review.
-
Ataxia telangiectasia mutated-dependent regulation of topoisomerase II alpha expression and sensitivity to topoisomerase II inhibitor.Cancer Sci. 2013 Feb;104(2):178-84. doi: 10.1111/cas.12067. Epub 2013 Jan 13. Cancer Sci. 2013. PMID: 23163762 Free PMC article.
-
PTEN stabilizes TOP2A and regulates the DNA decatenation.Sci Rep. 2015 Dec 10;5:17873. doi: 10.1038/srep17873. Sci Rep. 2015. PMID: 26657567 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous